Dr. Amar Sawhney

Amar is the Chairman and CEO of Instylla Inc., a biotechnology company specializing in hydrogel technology. Amarpreet was previously a President & CEO of Ocular Therapeutix, Inc. a company focused on ophthalmic drug delivery. He was also the Chairman of Augmenix, Inc., Founder and CEO of Confluent Surgical (acquired by Covidien), and the Chairman of MarketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence.